FMP
Acasti Pharma Inc.
ACST
NASDAQ
Inactive Equity
Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
3.37 USD
0.13 (3.86%)
Valuation Date:
Oct 25, 2024 4:00 PM
Share Price on Valuation Date
$3.37
Stock Beta
1.523
Shares Outstanding
10139900